MONTREAL, January 13 /PRNewswire/ --

- Integration Between SAND/DNA Access and EMC Centera Allows Customers to Store More Information at Their Fingertips, Lower TCO, Improve Operational Efficiencies and Meet Compliance Regulations

DENVER, January 13 /PRNewswire/ --

Jim Rogers and Beeland Interests, Inc. today announced the appointment of CQG, the leading analytics and order routing platform for global electronically traded futures markets, as the Official Global Calculation Agent for the Rogers International Commodity Index(R) (RICI(R)), as of 6:00 p.m., New York time, on Wednesday, January 14, effective for the first settlement on Thursday, January 15. CQG will calculate and distribute RICI(R) index values to end users directly over CQG terminals and via other quote vendors. CQG will also become a member of the Committee which is responsible for the Index.

The RICI(R) is a widely recognized measure of trends in global commodity prices.

NEW YORK, January 13 /PRNewswire/ --

TraderTools Inc. (TraderTools), a provider of business solutions, software and services to financial institutions trading FX, announced today that it closed a US$7.5 million round of financing on December 30, 2008. Edison Venture Fund, based in Lawrenceville, NJ, invested US$7 million, while company management invested US$500,000. The proceeds will be used to expand sales, marketing and development of TraderTools' Liquidity Management Platform(TM).

PHILADELPHIA, January 13 /PRNewswire/ --

- Virtual Enterprise Desktop helps provide real world network testing for application and software developers who create and support network-aware applications

AUSTIN, Texas, January 13 /PRNewswire/ --

- Vice President of Business Development, Jack Steeg, Brings 35 Years' Experience to Role

Ringdale Inc., the global leader in secure document output management solutions, has hired alliance veteran Jack Steeg as Vice President of Business Development, effective Dec 15, 2008. Steeg was hired to further enhance Ringdale's existing partner network and to help identify and recruit new strategic partners.

LONDON, January 13 /PRNewswire/ --

- Organizations Sharing International Brands Names Need to Act Now

Telnic Limited (http://www.telnic.org), the registry operator for the new .tel top level domain (TLD), today confirmed that Baidu Europe (http://www.baidu.eu), the Groningen-based automation and web design solutions organization, had secured the rights to the baidu.tel domain name, having been the first to apply for the domain name in the trademark protected Sunrise period. Telnic also urged organizations to seriously consider applying for them during the Sunrise period which closes on February 2nd 2009.

WASHINGTON, January 13 /PRNewswire/ --

- ICON Joins as Associate Member

The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, today announced that it has elected Dr. Derek Winstanly as Chair for 2009 and Mr. William Sharbaugh as Chair-Elect.

OTTAWA, Canada, January 13 /PRNewswire/ --

- Pronexus Announces Some of the Strongest Demand for Their VBVoice(R) IVR ToolKit

Pronexus announced today that INTERNET TELEPHONY magazine has named VBVoice 5.6 IVR ToolKit as a distinguished recipient of its 2008 Product of the Year Award.

WESTPORT, Connecticut, January 13 /PRNewswire/ --

- Will Franklin, J McLane, and Simon Munro Named Managing Directors

Lime Rock, a private equity firm focused on the global energy sector, today announces the naming of three new managing directors and several additional promotions. Longstanding team members Will Franklin, J McLane, and Simon Munro have all been named Managing Directors of the Lime Rock Partners team. Mr. Franklin and Mr. McLane are based in Lime Rock's Houston, Texas office, and Mr. Munro is based in the firm's Aberdeen, Scotland location. Mr. McLane joined the Lime Rock Partners team in 1998, at the firm's inception. Mr. Munro joined the team in 2002, and Mr. Franklin a year later.

BRITISH COLUMBIA, Canada, January 13 /PRNewswire/ --

InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces the completion of a large scale primate study confirming effectiveness and safety of its lead candidate DXL625 (CD20). The Company also announced that it has scheduled a meeting with the United States Food and Drug Administration (FDA) during the first half of 2009 to discuss the design of a clinical study.